Key Takeaways

  • Alpha does not exist in a vacuum; it is strictly an artifact of the chosen equilibrium risk model, a concept Eugene Fama drilled into his University of Chicago PhD students on day one.
  • The small-cap size effect fails as a rewarded factor once controlled for market beta; investors could match or beat small-cap returns by applying modest debt to large-cap equities at equivalent risk.
  • Modern systematic value investing abandons broad cross-sectional book-to-price screens across the whole market in favor of strict peer-group neutrality, such as comparing software companies strictly against software companies.
  • Theoretical alpha that fails to expand an allocator's specific opportunity set provides zero practical value to institutional portfolios.

The Myth of Baseline Alpha

On the first day of the doctoral program at the University of Chicago, Eugene Fama gave his students a clean rule: alpha is never absolute. It is an artifact of the baseline risk model chosen to define normal market equilibrium.

Peter Hecht, Managing Director at AQR Capital Management, still runs money on that premise. “And alpha is always relative to what model? What is your risk model?” Hecht notes. “So, and this was like what Gene Fama taught us in the PhD program at the University of Chicago on the first day of the PhD program. It's all relative to your market equilibrium.”

For institutional allocators, academic definitions of excess return matter far less than practical portfolio construction. If an active manager claims 200 basis points of alpha against a generic index, that excess return evaporates if the allocator already holds exposures that capture the same economic risks at a lower fee. Hecht argues that the true benchmark is an investor's existing opportunity set: “If some theoretical exercise says it has alpha, but doesn't improve your portfolio, it's dead to you, as far as I'm concerned.”

Beta Disguised as Size

The small-cap premium long stood as an article of faith in equity allocation. Classical factor literature suggested that buying smaller public companies yielded persistent excess returns over time. Systematic testing under precise market risk controls tells a different story.

Hecht points out that size functions purely as a risk exposure rather than a factor with positive structural expected return. When researchers match the market sensitivity of small caps against large caps, the small-cap outperformance disappears. An allocator holding large-cap equities could achieve the same or superior returns simply by scaling exposure up to match the higher beta of smaller companies, without paying liquidity costs or micro-cap trading friction.

Peer-Neutral Value Selection

Early quantitative value strategies relied on crude, market-wide accounting metrics. The original Fama-French value factor ranked every public company across a single index using raw book-to-price ratios. This approach produced structural sector biases, loading up on capital-heavy businesses during tech expansions and under-allocating to asset-light balance sheets.

AQR and modern systematic managers have rewritten those rules through industry-neutral factor construction and machine learning tools, including word embeddings applied to regulatory filings and earnings transcripts. The goal is removing sector noise while isolating relative mispricings within precise peer groups.

“When we think about implementing value and a lot of thoughtful managers, it's within a peer group where it's apples to apples,” Hecht explains. “It's a utility company versus utility company. It's a tech company versus a tech while the simple Fama French was just across the entire universe.”

Why It Matters

This analytical shift signals that institutional allocators are abandoning broad factor tilts in favor of risk-neutral, idiosyncratic selection. As systematic strategies replace blunt market-wide multiples with machine-learning-driven peer comparisons, the bar for active managers to prove genuine diversification over cheap index beta continues to rise.